Mesenchymal stromal cells (MSCs) are under investigation for wound healing and tissue
regeneration due to their potent secretome. Compared to monodisperse cells, MSC …

Mesenchymal stem cell therapies promote wound healing by manipulating the local
environment to enhance the function of host cells. Aggregation of mesenchymal stem cells …

Mesenchymal stem cells (MSCs) secrete endogenous factors such as vascular endothelial
growth factor (VEGF) and prostaglandin E2 (PGE 2) that promote angiogenesis, modulate …

Mesenchymal stromal/stem cells (MSCs) typically require significant ex vivo expansion to
achieve the high cell numbers required for research and clinical applications. However …

Mesenchymal stem cell (MSC)-based therapies are under broad investigation for
applications in tissue repair but suffer from poor cell persistence and engraftment upon …

Mesenchymal stem cells (MSCs) are essential in regenerative medicine. However,
conventional expansion and harvesting methods often fail to maintain the essential …

Chronic wounds are a source of substantial morbidity for patients and are a major financial
burden for the healthcare system. There are no current therapies that reliably improve …

Cell therapies offer a tailorable, personalized treatment for use in tissue engineering to
address defects arising from trauma, inefficient wound repair, or congenital malformation …

Mesenchymal stem/stromal cells (MSCs) hold great promise in bioengineering and
regenerative medicine. MSCs can be isolated from multiple adult tissues via their strong …

The clinical translation of mesenchymal stromal cell (MSC)‐based therapies remains
challenging due to rapid cell death and poor control over cell behavior. Compared to …